Cerecor Inc (CERC) Fundamental Analysis & Valuation

NASDAQ:CERC

Current stock price

2.93
-0.05 (-1.68%)
At close:
2.9468
+0.02 (+0.57%)
After Hours:

This CERC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CERC Profitability Analysis

1.1 Basic Checks

  • In the past year CERC has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -119.98%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -1201.64%
PM (TTM) -1194.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. CERC Health Analysis

2.1 Basic Checks

  • CERC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

  • Based on the Altman-Z score of -4.37, we must say that CERC is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.79 indicates that CERC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z -4.37
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 2.19 indicates that CERC has no problem at all paying its short term obligations.
  • A Quick Ratio of 2.18 indicates that CERC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.18

3

3. CERC Growth Analysis

3.1 Past

  • CERC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.12%.
  • The Revenue has decreased by -6.39% in the past year.
  • The Revenue for CERC have been decreasing by -37.78% on average. This is quite bad
EPS 1Y (TTM)-49.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-37.78%
Revenue growth 5YN/A
Sales Q2Q%150.78%

3.2 Future

  • CERC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.94% yearly.
  • Based on estimates for the next years, CERC will show a very strong growth in Revenue. The Revenue will grow by 120.79% on average per year.
EPS Next Y4.09%
EPS Next 2Y11.13%
EPS Next 3Y16.75%
EPS Next 5Y7.94%
Revenue Next Year-12.27%
Revenue Next 2Y17.22%
Revenue Next 3Y104.26%
Revenue Next 5Y120.79%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CERC Yearly Revenue VS EstimatesCERC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CERC Yearly EPS VS EstimatesCERC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2

0

4. CERC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CERC. In the last year negative earnings were reported.
  • Also next year CERC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CERC Price Earnings VS Forward Price EarningsCERC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.42
CERC Per share dataCERC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • CERC's earnings are expected to grow with 16.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.13%
EPS Next 3Y16.75%

0

5. CERC Dividend Analysis

5.1 Amount

  • No dividends for CERC!.
Industry RankSector Rank
Dividend Yield N/A

CERC Fundamentals: All Metrics, Ratios and Statistics

Cerecor Inc

NASDAQ:CERC (8/25/2021, 8:25:06 PM)

After market: 2.9468 +0.02 (+0.57%)

2.93

-0.05 (-1.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.01%
Inst Owner Change0%
Ins Owners3.95%
Ins Owner Change0%
Market Cap281.31M
Revenue(TTM)6.43M
Net Income(TTM)-76.89M
Analysts100
Price Target6.63 (126.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.72
P/FCF N/A
P/OCF N/A
P/B 13.03
P/tB N/A
EV/EBITDA -3.42
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.07
BVpS0.22
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -119.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1201.64%
PM (TTM) -1194.83%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 2.18
Altman-Z -4.37
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
EPS Next Y4.09%
EPS Next 2Y11.13%
EPS Next 3Y16.75%
EPS Next 5Y7.94%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-37.78%
Revenue growth 5YN/A
Sales Q2Q%150.78%
Revenue Next Year-12.27%
Revenue Next 2Y17.22%
Revenue Next 3Y104.26%
Revenue Next 5Y120.79%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Cerecor Inc / CERC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Cerecor Inc (CERC) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CERC.


What is the valuation status of Cerecor Inc (CERC) stock?

ChartMill assigns a valuation rating of 0 / 10 to Cerecor Inc (CERC). This can be considered as Overvalued.


Can you provide the profitability details for Cerecor Inc?

Cerecor Inc (CERC) has a profitability rating of 0 / 10.


What is the earnings growth outlook for Cerecor Inc?

The Earnings per Share (EPS) of Cerecor Inc (CERC) is expected to grow by 4.09% in the next year.